Thin-layer chromatographic‒densitometric method of analysis for the estimation of montelukast and bilastine in combination
- 30 August 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Planar Chromatography – Modern TLC
- Vol. 34 (4), 289-295
- https://doi.org/10.1007/s00764-021-00120-w
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Degradation kinetics of Bilastine determined by RP-HPLC method and identification of its degradation product in oxidative conditionChemical Papers, 2019
- UV SPECTROPHOTOMETRIC METHOD FOR QUANTITATIVE DETERMINATION OF BILASTINE USING EXPERIMENTAL DESIGN FOR ROBUSTNESSDrug Analytical Research, 2017
- Newly Developed and Validated Method of Montelukast Sodium Estimation in Tablet Dosage Form by Ultraviolet Spectroscopy and Reverse Phase - High Performance Liquid ChromatographyPharmacology, Toxicology and Biomedical Reports, 2016
- Bilastine: new insight into antihistamine treatmentClinical and Molecular Allergy, 2015
- Antileukotriene Agents for the Treatment of Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- BilastineDrugs, 2012
- Development and validation of a RP-HPLC method for estimation of montelukast sodium in bulk and in tablet dosage formIndian Journal of Pharmaceutical Sciences, 2010
- An Automated Method for the Determination of Montelukast in Human Plasma Using Dual-Column HPLC Analysis and Peak Height Summation of the Parent Compound and Its Photodegradation ProductPharmaceutical Research, 2004
- HPTLC determination of montelukast sodium in bulk drug and in pharmaceutical preparationsJournal of Planar Chromatography – Modern TLC, 2004
- Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene–receptor antagonist, at the end of a once-daily dosing interval*Clinical Pharmacology & Therapeutics, 1997